Elsevier

Brain Research

Volume 784, Issues 1–2, 16 February 1998, Pages 299-304
Brain Research

Research report
Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study

https://doi.org/10.1016/S0006-8993(97)01381-4Get rights and content

Abstract

Since calcium activated neutral proteinase (calpain) is present in the central nervous system (CNS) and degrades myelin proteins, this endopeptidase has been suggested to play a role in myelin destruction in demyelinating diseases such as multiple sclerosis (MS). In the present study, calpain immunocytochemical expression was examined in Lewis rats with acute experimental allergic encephalomyelitis (EAE), an animal model for MS and optic neuritis. To identify cells expressing calpain, we labeled rat optic nerve sections for calpain with a polyclonal myelin calpain antibody and with monoclonal antibodies for glial (GFAP, OX42) and inflammatory (CD2, ED2, ED1, IFN-γ) cell-specific markers. The results showed increased calpain expression in microglia (OX42) and infiltrating macrophages (ED1,2) in EAE compared to normal controls. Astrocytes constitutively expressed calpain in controls and acute EAE. Reactive astrocytes in EAE located in or near inflammatory foci, exhibited markedly increased calpain expression. Most T cells in acute EAE showed low level calpain expression while activated IFN-γ-producing lymphocytes in inflammatory foci exhibited elevated levels of calpain expression. Thus, our results demonstrate increased calpain expression (at transcriptional and/or translational levels) in a rat model of optic neuritis. A role for calpain in myelin destruction during optic neuritis may be relevant to the pathogenesis of this disorder.

Introduction

Optic neuritis is a demyelinating condition of the optic nerve that often appears as a presenting feature of multiple sclerosis (MS). Symptoms of optic neuritis include blurred vision, pain on eye movement, and blindness, which may develop over periods of hours to days and improve during the following months. Visual abnormalities are accompanied by axonal conduction block and increased blood brain barrier permeability which are often associated with demyelination [9]. Experimental allergic encephalomyelitis (EAE) has been used as an animal model for uveitis and optic neuritis 7, 22, 23, 24. Although the mechanism of demyelination is unknown, the demyelinating features present in the optic nerve in this disease are similar to those found in the spinal cord. Matsumoto et al. [19], showed microglial proliferation during the initial and peak stages of EAE with astrocyte activation occurring during the onset of the recovery stage. Using flow cytometry and histochemical techniques, Banati et al. [1], observed secretory proteinases including cathepsins B and L in microglia which may participate in myelin destruction if released during initial and peak stages of EAE. In addition to microgliosis, infiltrating T cells are observed in EAE lesions. Activated T cells have been shown to release proteinases including calpain and may also participate in demyelination [11].

Calpain is present in all cell types so far studied, and has been shown to degrade axonal and myelin proteins including myelin basic protein (MBP), neurofilament proteins, and myelin associated glycoprotein 3, 14. The degradation of these proteins at physiological pH, suggests calpain may play a role in demyelinating diseases (e.g., MS) and tissue destruction in spinal cord injury 4, 15. Until activated by increased calcium levels calpain remains a proenzyme, but calpain expression and secretion may be upregulated in stimulated glial and inflammatory cells such as those occurring in optic neuritis lesions. Optic nerve is composed of myelinated axons and glial cells, the latter undergoing activation and proliferation during the peak stage of optic neuritis. In order to examine the role of calpain in optic neuritis, we employed immunoperoxidase and fluorescent double-labeling techniques to explore changes in calpain expression in glial and infiltrating inflammatory cells. We found markedly increased calpain immunoreactivity in microglia, macrophages, and astrocytes in the optic nerves of rats with experimental optic neuritis compared to controls. A preliminary report of this work has been previously presented [26].

Section snippets

Antibodies

The polyclonal calpain antibody (1:200 dilution) was raised in rabbits and characterized 2, 8. The monoclonal antibodies used were as follows: OX42 (specific for microglia) for complement receptor type 3 13, 21at 1:150 dilution; ED2-macrophage membrane glycoprotein at 1:200; ED1-for phagocytic lysosomal membrane protein [5]at 1:100; GFAP MIG-G2 clone-for astrocyte intermediate filament protein at 1:100 and rat-specific IFN-γ at 1:200 were purchased from Biosource (Camarillo, CA). Monoclonal

Results

Control optic nerve showed evenly dispersed, normal glial cells by H&E staining (Fig. 1A). An increased number of cells was visible in optic nerves of animals with grade 4 EAE (Fig. 1B). Cells appeared in clusters and were often observed along vessels (perivascular cuffing) and within the subdural spaces—consistent with mononuclear cell infiltration of the CNS. Single immunoperoxidase staining for calpain in optic nerves from EAE animals also showed increased numbers of calpain-positive cells

Discussion

The expression of calpain in both rabbit and Lewis rat optic nerves is already known 6, 26. Although the enzyme has been identified in optic nerve glia, lens and retinal ganglion cells, calpain-specific cells have not been clearly identified in optic neuritis 20, 25. Since gliosis and inflammatory infiltrates are hallmarks of optic neuritis, we studied calpain expression by astrocytes, microglia, T cells, and macrophages in the Lewis rat optic nerve during the peak stage of EAE.

The present

Acknowledgements

This work was supported in part by grants from NIH-NINDS NS-31622, SCRF-1238 from the Paralyzed Veterans of America, RG-2130B2 from the National Multiple Sclerosis Society, and MUSC Medical Scientist Training Program (Donald Shields). Technical assistance by George W. Ohlandt and critical review of data and manuscript by Edward L. Hogan, M.D. and Cedric S. Raine, PhD are greatly appreciated.

References (27)

  • J. Bauer et al.

    Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis

    J. Neurosci. Res.

    (1994)
  • S.J. Bullington et al.

    Uveitis in rabbits with experimental allergic encephalomyelitis

    Arch. Ophthal.

    (1958)
  • A.K. Chakrabarti et al.

    Calcium-activated neutral proteinases in rat brain and subcellular fractions

    J. Neurosci. Res.

    (1988)
  • Cited by (32)

    • Lysophosphatidic acid: Chemical signature of neuropathic pain

      2013, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
      Citation Excerpt :

      This observation raises the possibility of two complementary pathways directly involved in demyelination; a rapid-acting non-genomic pathways and a little late phase that involves transcriptional repression of myelin-related genes. Research evidence suggesting the involvement of calpain in the non-genomic component of oligodendrocyte-related (or multiple sclerosis-related) demyelination is now mounting [20,62–64]. The calpain involvement is also the case with SC-related demyelination following nerve injury [17].

    View all citing articles on Scopus
    View full text